Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Stage cT3 low rectal cancer: analysis of prognostic factors126
Anatomical observation and clinical significance of the left gastric vein in laparoscopic radical gastrectomy44
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study25
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i25
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study24
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study24
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms23
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment22
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma21
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report21
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments21
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database20
Prognostic nomogram for T3–T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis19
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study19
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions19
Rectal tumor fragmentation as a response pattern following chemoradiation19
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis19
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor18
The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma18
Prediction of early recurrence in patients with colorectal liver metastases18
CBX3 is associated with metastasis and glutathione/glycosphingolipid metabolism in colon adenocarcinoma18
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database17
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients16
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling16
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol15
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospecti15
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma15
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer14
LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma14
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes14
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients14
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?13
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor13
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage12
Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients12
Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study12
Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer12
What is the significance of mismatch repair deficiency in stage IV colon cancer?12
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study12
The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery11
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers11
Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas11
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?11
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?11
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis11
Duodenal neuroendocrine tumors: how safe is endoscopic resection?11
Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study11
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation11
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer11
Gastric and colorectal cancer incidence attributable to dietary factors in Korea11
Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study11
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection11
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank11
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer11
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer11
A bioinformatics analysis of potential cellular communication networks in non-alcoholic steatohepatitis and colorectal adenoma using scRNA-seq and bulk-seq11
Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression11
Treatment at a high-volume academic research program mitigates racial disparities in pancreatic adenocarcinoma10
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review10
Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer10
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection10
A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery10
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition10
A comparison of two methods of lymph node dissection along the left recurrent laryngeal nerve in McKeown minimally invasive esophagectomy10
Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report10
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responses10
KCNC3 as a prognostic indicator and a predictive marker for immunotherapy in colorectal cancer10
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab10
Slug and CD133 expression are associated with peritoneal carcinomatosis and survival in gastric cancer10
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis10
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM310
Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids10
Risk of de novo esophageal cancer in liver transplant recipients: systematic review and meta-analysis10
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model10
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?10
MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance10
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II–III colorectal cancer10
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome10
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds10
The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review10
Mismatch repair deficiency confers worse survival in stage IV colon cancer9
IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma9
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin9
Digestive tract reconstruction of laparoscopic total gastrectomy for gastric cancer: a comparison of the intracorporeal overlap, intracorporeal hand-sewn anastomosis, and extracorporeal anastomosis9
Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: a novel predictive model9
Prognostic performance of different lymph node classification systems in young gastric cancer9
Increasing colorectal cancer screening uptake—time to consider a more holistic socio-ecological approach9
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomiz9
Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer9
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical study9
Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma9
Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review9
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study9
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report9
Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway9
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report9
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER datab9
Clinical outcomes of definitive radiotherapy for patients with cT1aN0M0 esophageal cancer unsuitable for endoscopic resection and surgery8
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis8
PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-68
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis8
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study8
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies8
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma8
Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer8
The brain–gut axis in gastrointestinal cancers8
The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis8
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database8
Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms8
Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score match8
Impact of prolonged surgical waiting time on cancer-specific mortality in stage I–II pancreatic ductal adenocarcinoma patients who received radical resection8
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma8
Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellu8
Development and experimental validation of a senescence-related long non-coding RNA signature for prognostic prediction and immune microenvironment characterization in gastric cancer patients8
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study8
KRAS gene status in gastric signet-ring cell carcinoma patients and acts as biomarker of MEK inhibitor8
Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study8
Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer8
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective st8
Unexpected plasmablastic lymphoma in a young adult with unknown HIV infection: case report8
High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study8
Model construction and risk analysis of the lncRNA genes associated with the prognosis of esophageal adenocarcinoma with immune infiltration7
Inflammatory pseudotumor-like extranodal classic Hodgkin lymphoma manifesting as bowel perforation in acquired immunodeficiency syndrome patient with disseminated leishmaniasis: a case report and appr7
Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report7
Rare germline chromosome 1 duplication identified in young male with colon cancer: a case report investigating causality7
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway7
Integrated omics analysis: the relationship between significantly increased Klebsiella post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failur7
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin7
Comparative study on short-term efficacy of single incision plus one (SI+1) port and multiportal 3D laparoscopic minimally invasive esophagectomy7
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin7
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation7
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer7
Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p7
Radiofrequency ablation has similar short-term effects but significantly lowers the long-term effect compared with routine resection in the treatment of small hepatocellular carcinoma7
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?7
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?7
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor7
RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes7
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility7
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study7
Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System7
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis7
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway7
Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma7
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX7
Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma7
Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis7
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology7
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients6
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma6
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels6
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature6
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report6
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study6
Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings6
Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital6
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction6
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis6
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway6
The emerging role of intra-tumoral bacteria6
Value-based chronic care model approach for vulnerable older patients with multiple chronic conditions6
Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas6
Development and validation of a dual-energy CT-based model to estimate the malignant probability of distal gastric wall thickening6
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram6
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis6
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma6
Primary gastric squamous cell carcinoma in a young adult with immunotherapy complications: a case report6
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis6
Helicobacter pylori-induced protein tyrosine phosphatase receptor type C as a prognostic biomarker for gastric cancer6
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis6
Erratum to Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo6
Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis6
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression6
Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma6
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer6
Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients6
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment6
ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer6
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study6
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway6
A prognostic nomogram based on desmoplastic reaction/tumor deposit modified lymph node staging in colorectal cancer6
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial6
Current management of gastric adenocarcinoma: a narrative review6
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort6
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells6
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer6
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma6
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma6
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes5
SPP1 promotes tumor progression in esophageal carcinoma by activating focal adhesion pathway5
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two ph5
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line tre5
A narrative review of the evolving role of immunotherapy in the management of esophageal and gastric cancer5
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therap5
Analysis of the efficacy and safety of paclitaxel (albumin-bound) combined with S-1 and oxaliplatin combined with S-1 in the first-line treatment of advanced gastric cancer: a cohort study5
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma5
The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer5
Identification of 8-gene risk prediction signature associated with NOTCH1 in stomach adenocarcinoma based on bioinformatics analysis5
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment5
Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report5
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study5
Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients5
Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis5
Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation5
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer5
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data5
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients5
Combined detection of preoperative neutrophil to lymphocyte ratio and interleukin-6 as an independent prognostic factor for patients with non-metastatic colorectal cancer5
Promotion of perineural invasion of cholangiocarcinoma by Schwann cells via nerve growth factor5
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study5
Development and validation of a nomogram based on neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio for predicting recurrence of colorectal adenoma5
The role of TMSB15A in gastric cancer progression and its prognostic significance5
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study5
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study5
Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study5
Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma5
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review5
A case series of 10 patients undergone linear cutter/stapler guiding device-led overlapped esophagojejunostomy: a preliminary study5
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancer5
TSC1/2 mutations—a unique type of mutation suitable for liver transplantation of Hepatocellular carcinoma5
Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions5
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO25
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy5
The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer5
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer5
Correlation between microvessel density (MVD) and multi-spiral CT (MSCT) perfusion parameters of esophageal cancer lesions and the diagnostic value of combined CtBP2 and P16INK4A5
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging5
A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma5
Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma5
Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma5
Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis5
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma5
Outcomes in octogenarians following elective colorectal cancer surgery5
Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma5
Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers5
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer5
Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer5
Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells5
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy5
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report5
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cance4
Expression of Claudin18.2 in metastatic lesions in peritoneum of gastric cancer4
Effects of magnetic resonance imaging (MRI)-detected extramural vascular invasion (mrEMVI) and tumor deposits (TDs) on distant metastasis and long-term survival after surgery for stage III rectal canc4
Comparison of various liver cancer staging systems in predicting prognosis after initial transcatheter arterial chemoembolization: a retrospective study from China4
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway4
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review4
Safety of biliary stent placement followed by definitive chemoradiotherapy in patients with pancreatic cancer with bile duct obstruction4
Predictive models of lymph node metastasis in patients with gastrointestinal stromal tumors based on machine learning algorithms: a SEER-based retrospective study4
Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis4
Molecular characterization of squamous cell carcinoma of the anal canal4
0.094397068023682